-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
In This Section
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
News
-
Apply by January 26 for USPTO Examination of Ranges Course
January 24, 2020
The US Patent and Trademark Office will brief users on recent examination practice and procedure guidance related to examination of ranges during its Virtual Instructor Led Training (vILT) course Examination of Ranges on February 11, 12, or 13. -
Nidec Zooms Over Patent Infringement Claims in Fed. Cir.
January 23, 2020
The Federal Circuit on January 10, 2020, held that patent infringement claims against Japanese electric motor manufacturer Nidec Corp. were barred by a covenant not to sue, and found that the covenant was not superseded by a later agreement involving the same patent. -
CBS Captures Win in Podcasting Patent Infringement Squabble
January 22, 2020
CBS Corp. won’t have to pay a $1.3 million infringement award because a podcasting patent was invalidated by the Patent Trial and Appeal Board (PTAB), the Federal Circuit said on January 10, 2020. -
Hospira Loses Appeal of Sedative Patent Invalidity Decision
January 20, 2020
The US Court of Appeals for the Federal Circuit on January 9, 2020, affirmed the US District Court for the Northern District of Illinois’s ruling which held that a claim of Hospira’s Precedex Premix sedative was invalid for obviousness. -
USPTO Toolkit Now Available for Those New to PTAB Proceedings
January 17, 2020
The US Patent and Trademark Office on January 15, 2020, released a “New to PTAB” toolkit now available on the PTAB webpage of the USPTO website.